UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-QSB/A
Amendment No. 1
Quarterly Report Under Section 13 or 15(d)
of the Securities Exchange Act of 1934
For the quarterly period ended June 30, 2002 Commission file number 0-18170
------------- -------
CRYOMEDICAL SCIENCES, INC.
--------------------------
(Exact name of small business issuer as specified in its charter)
Delaware 94-3076866
-------- ----------
State of Incorporation) (IRS Employer I.D. Number)
Suite 144 - Science III.
SUNY Park
Binghamton, NY 13902
--------------------
(Address of principal executive offices)
Issuer's telephone number, including area code: (607) 777-4415
--------------
Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes X No
---- ----
12,413,209 SHARES OF CRYOMEDICAL SCIENCES, INC. COMMON STOCK, PAR VALUE $.001
PER SHARE, WERE OUTSTANDING AS OF AUGUST 13, 2002.
PART II - OTHER INFORMATION
ITEM 5. OTHER INFORMATION
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits
99.1 Certification of Periodic Report
(b) Reports on Form 8-K
Form 8-K, filed July 10, 2002, relating to the sale of the Company's
cryosurgical assets to Endocare.
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
Cryomedical Sciences, Inc.
--------------------------
(Registrant)
Date: August 16, 2002 By: /s/ John G. Baust
-----------------
John G. Baust, PhD
President and Chief Executive Officer
(Principal Executive Officer and
Principal Financial Officer)